A Gemcitabine based liposomal formulation for treatment of cancer and a process for preparing the same is disclosed, wherein said formulation comprises a lipid mixture, gemcitabine and optionally a folate ligand. Further, the lipid mixture comprises Hydrogenated soy phosphatidylcholine, cholesterol, and Digalactosyl...